Abstract:Background: Telomerase is a ribonucleoprotein complex consisting of a catalytic component telomerase reverse transcriptase (TERT), internal RNA template and other co-factors, and its essential function is to synthesize telomeric DNA, repetitive TTAGGG sequences at the termini of linear chromosomes. Telomerase is silent in normal human follicular thyroid cells, primarily due to the TERT gene being tightly repressed. During the development and progression of thyroid carcinomas (TCs), TERT induction and telomerase activation is in general required to maintain telomere length, thereby conferring TC cells with immortal and aggressive phenotypes. Methods: The genomic alterations of the TERT loci including TERT promoter's gain-of-function mutations, copy number gain, fusion and rearrangements, have recently been identified in TCs as mechanisms to induce TERT expression and to activate telomerase. Importantly, numerous studies have consistently shown that TERT promoter mutations and TERT expression occur in all TC subtypes, and are robustly associated with TC malignancy, aggressiveness, treatment failure and poor outcomes. Therefore, the assessment of TERT promoter mutations and TERT expression is highly valuable in TC diagnostics, prognosis, treatment decision, and follow-up design. In addition, the TERT promoter is frequently hypermethylated in TC cells and tumors, which is required to activate TERT transcription and telomerase. Dysregulation of other components in the telomerase complex similarly upregulate telomerase. Moreover, shortened telomeres lead to altered gene expression and metabolism, thereby actively promoting TC aggressiveness. Here we summarize recent findings in TCs to provide the landscape of TC-featured telomere/telomerase biology and discuss underlying implications in TC precision medicine. Conclusion: Mechanistic insights into telomerase activation and TERT induction in TCs are important both biologically and clinically. The TERT gene aberration and expression-based molecular classification of TCs is proposed, and for such a purpose, the standardization of the assay and evaluation system is required. Moreover, the TERT-based system and 2022 WHO TC classification may be combined to improve TC care.

Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer

Role of TERRA in the Regulation of Telomere Length

The regulations of telomerase reverse transcriptase (TERT) in cancer

Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players

Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications

Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer

Regulation Of Telomerase Activity By Apparently Opposing Elements

Thyroid carcinoma-featured telomerase activation and telomere maintenance: Biology and translational/clinical significance

Regulation of human telomerase in homeostasis and disease

Transcriptional regulation mechanism and targeted cancer therapy of human telomerase reverse transcriptase promoter

Regulation of telomerase towards tumor therapy

Multiple Actions of Telomerase Reverse Transcriptase in Cell Death Regulation

MicroRNA Regulation of Telomerase Reverse Transcriptase (TERT): Micro Machines Pull Strings of Papier-Mâché Puppets

Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene

Research Progress of Non-telomeric Functions of Telomerase

Noncanonical functions of telomerase and telomeres in viruses‐associated cancer

Telomere and Telomerase Therapeutics in Cancer

Telomerase RNA TERC and the PI3K-AKT pathway form a positive feedback loop to regulate cell proliferation independent of telomerase activity

Transcriptional Regulation of Telomerase Activity

Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes